Key result
IV amiodarone successfully treats a case of pre-excited AF despite guideline prohibitions.
Why the study?
Recent guidelines forbid intravenous amiodarone for pre-excited AF due to ventricular fibrillation risk, despite its effectiveness, while some physicians continue to favor it successfully.
Case Report (n=1)
Highlights a case where intravenous amiodarone was successfully used for pre-excited atrial fibrillation despite current guidelines forbidding its use.
Should not change practice for pre-excited AF; Level 5 case leaves open need for prospective safety data.
Electrical cardioversion or intravenous ibutilide are currently recommended as the acute treatment for pre-excited atrial fibrillation. Recent guidelines for this circumstance forbid intravenous amiodarone despite its effectiveness in blocking the accessory pathway and atrioventricular node due to the possibility of ventricular fibrillation. But as our presented case, some physicians continued to favor intravenous amiodarone successfully in a suitable setting.
No takes yet. Share an insight, caveat, or question.
Payami et al. (2023) conducted a case report in Pre-excited atrial fibrillation (n=1). Intravenous amiodarone was evaluated. Intravenous amiodarone was successfully used to treat a case of pre-excited atrial fibrillation in the emergency department, despite guideline prohibitions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: